# BioLife Plasma Services, L.P. – FDA 483, Jun 8, 2026

Source: https://www.keypedia.com/records/483/biolife-plasma-services-lp/d75dc6e4-45eb-400e-9f0f-8489c1999ea7

> FDA 483 for BioLife Plasma Services, L.P. on June 08, 2026. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: BioLife Plasma Services, L.P.
- Inspection Date: 2026-06-08
- Product Type: biologics
- Office Name: Denver District Office
- Summary: An FDA inspection of BioLife Plasma Services, L.P. in Glendale, AZ, a plasma center, revealed significant deficiencies. The firm failed to thoroughly investigate post-donation adverse reactions and maintain equipment according to manufacturer instructions. Additionally, standard operating procedures were found to be inadequate for investigating adverse donor and recipient reactions, and the quality team lacked proper oversight of complaint handling.

## Related Officers

- [Emily S. McGann](https://www.keypedia.com/people/emily-s-mcgann/43891ff3-bd70-4337-b61c-e16cc7ad0468)

Company: https://www.keypedia.com/companies/biolife-plasma-services-lp/72d2055c-393d-4c0f-88ba-47f2101d2b62

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face